戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ple system atrophy, including a patient with visual hallucinations.
2 ry hallucinations, but not the subgroup with visual hallucinations.
3 al hallucinations, relative to those without visual hallucinations.
4 sential components of a model of oscillating visual hallucinations.
5 echanism underlying 5-HT2A receptor-mediated visual hallucinations.
6  of visual perceptual alterations, including visual hallucinations.
7 al feedback mechanisms can enhance patterned visual hallucinations.
8 utes to the observed regularity of geometric visual hallucinations.
9           These are experienced as geometric visual hallucinations.
10 nitive function in patients with and without visual hallucinations.
11  was made for reporting of persistent formed visual hallucinations.
12 and executive function, were associated with visual hallucinations.
13 y in visual recognition to social vision and visual hallucinations.
14 n the clinical study of whom 32% experienced visual hallucinations.
15 eelings of presence and passage) and complex visual hallucinations.
16  particularly for patients with a history of visual hallucinations.
17 the left ILF (P = .02) than patients without visual hallucinations.
18  suggest three mechanisms underlying complex visual hallucinations.
19 considering current models for mechanisms of visual hallucinations.
20  alterations in visual perception, including visual hallucinations.
21 erse events for ADS-5102 vs placebo included visual hallucinations (15 [23.8%] vs 1 [1.7%]), peripher
22 sm symptoms-71 years (66-92 years), six with visual hallucinations-72 years (64-90 years), seven with
23  differences in ocular pathology between the visual hallucination and non-visual hallucination groups
24 hy patient group included hyper-religiosity, visual hallucinations and cross-modal sensory experience
25                                              Visual hallucinations and illusions are thought to be ca
26                          Fifty patients with visual hallucinations and illusions secondary to degener
27 ctively contribute to the pathophysiology of visual hallucinations and may explain their predominantl
28 s associated with the presence of persistent visual hallucinations and persistent delusions.
29 d cognitive decline with new-onset recurrent visual hallucinations and progressive lethargy.
30 variables persecutory ideation, auditory and visual hallucinations, and diagnosis of probable psychos
31 he possible neuronal events at the origin of visual hallucinations, and further suggests that brain o
32 ypes include myoclonic seizures, auditory or visual hallucinations, and renal failure.
33                             Procaine-induced visual hallucinations appeared associated with greater g
34                                              Visual hallucinations are frequent, disabling complicati
35  in Parkinson's disease and, with respect to visual hallucinations, are an important predictor of cog
36  predominant effects induced by LSD included visual hallucinations, audiovisual synesthesia, and posi
37 n in Alzheimer's disease, as were persistent visual hallucinations, but patients who had dementia wit
38 -HT2A receptors may lead to the formation of visual hallucinations by increasing cortical excitabilit
39                                              Visual hallucinations can be a major hallmark of late st
40                            Here we show that visual hallucinations can be induced in the normal popul
41 between the presence of the Ser23 allele and visual hallucinations (chi2 = 7.5, df = 1, P = 0.006) (P
42 estones of advanced disease (frequent falls, visual hallucinations, cognitive disability and need for
43  older and had an extremely low frequency of visual hallucinations compared with Parkinson's disease.
44 grey matter atrophy patterns associated with visual hallucinations, comparing Parkinson's disease hal
45 he link between abnormal visual function and visual hallucinations, considering current models for me
46 ionships of persistent psychiatric symptoms (visual hallucinations, delusions, depression) to plaques
47 estones of advanced disease (frequent falls, visual hallucinations, dementia and need for residential
48 ribed by several different authors as formed visual hallucinations due to disturbances of the visual
49 , the hallucinators, all of whom experienced visual hallucinations, exhibited grey matter atrophy wit
50 ons to the hippocampus and cortex, while the visual hallucinations experienced by subjects with Demen
51 ch in peduncular hallucinosis, a syndrome of visual hallucinations following subcortical lesions long
52                              Patients in the visual hallucinations group had similar disease duration
53 ogy between the visual hallucination and non-visual hallucination groups.
54 ses revealed that patients with a history of visual hallucinations had lower fractional anisotropy in
55 cted for multiple comparisons, patients with visual hallucinations had significantly greater disease
56                                              Visual hallucinations, illusions and extrapyramidal trac
57  profile correlated strongly with ratings of visual hallucinations, implying that intrinsic brain act
58 nary incontinence in 50% and dementia in 39%.Visual hallucinations in 0%.
59                    The literature related to visual hallucinations in ophthalmological settings from
60                    The exact pathogenesis of visual hallucinations in Parkinson's disease is not know
61 mographic and ophthalmological correlates of visual hallucinations in Parkinson's disease, the combin
62 endently contributing to the pathogenesis of visual hallucinations in Parkinson's disease.
63  connectome, and lead to the hypothesis that visual hallucinations in patients with COS may be becaus
64 reases appeared to correlate positively with visual hallucination intensity.
65                        Current research into visual hallucination is predominantly ophthalmology-led,
66                                      Complex visual hallucinations may affect some normal individuals
67   Transient monocular visual loss or complex visual hallucinations may lead to neuroanatomic ambiguit
68 tion and the wider clinical context in which visual hallucinations occur.
69 ness and transient delusions and auditory or visual hallucinations occurred in the majority.
70 where loss of vision leads to complex, vivid visual hallucinations of objects, people, and whole scen
71 ent, migraine coma, Charles Bonnet syndrome (visual hallucinations of the blind), schizophrenia, hall
72 any drug (OR, 9.41; 95% CI, 5.26-16.85), and visual hallucinations (OR, 2.13; 95% CI, 1.10-4.13).
73  The milestones of dementia (P < 0.0005) and visual hallucinations (P = 0.02) as well as the accumula
74 ng cognitive impairment, attention deficits, visual hallucinations, parkinsonism, and other neuropsyc
75 ficits included a small visual field defect, visual hallucinations, prosopagnosia, topographical diso
76 ns in subjects with Parkinson's disease with visual hallucinations, relative to those without visual
77 2.1 [5.1] years; P = .03), had more frequent visual hallucinations that did not achieve significance
78 ommon and sometimes curious, if not bizarre, visual hallucinations, the forms of which suggest that e
79 to both fMRI and iEEG, induced a topographic visual hallucination: the patient described seeing indoo
80 cking of this oscillation is correlated with visual hallucinations, thought disorder, and disorganiza
81  significant and consistent risk factors for visual hallucinations, together with new evidence to sug
82 The Charles Bonnet syndrome is a disorder of visual hallucinations typically occurring in older perso
83                              For many years, visual hallucinations (VH) in idiopathic Parkinson's dis
84 ht into the pathophysiological mechanisms of visual hallucinations (VHs) in patients with Parkinson d
85                                              Visual hallucinations (VHs) occur in macular degeneratio
86               The frequency of delusions and visual hallucinations was increased in Parkinson's disea
87 in neuropathological correlate of persistent visual hallucinations was the presence of less severe ta
88 bodies, which is hypothesized to account for visual hallucinations, we found connectivity with this r
89  at death 75.5 +/- 8.0 years) and persistent visual hallucinations were documented in 63%.
90 ies and Alzheimer's disease for auditory and visual hallucinations were especially pronounced for pat
91                                              Visual hallucinations were more common in the group with
92 n model the four independent determinants of visual hallucinations were rapid eye movement sleep beha
93 erential diagnosis, depicting other forms of visual hallucination which result from a variety of non-

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。